Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 122; no. 7; p. 2702
Main Authors Ma, Cynthia X., Cai, Shirong, Li, Shunqiang, Ryan, Christine E., Guo, Zhanfang, Schaiff, W. Timothy, Lin, Li, Hoog, Jeremy, Goiffon, Reece J., Prat, Aleix, Aft, Rebecca L., Ellis, Matthew J., Piwnica-Worms, Helen
Format Journal Article
LanguageEnglish
Published American Society for Clinical Investigation 02.07.2012
Subjects
Erratum
Online AccessGet full text

Cover

More Information
ISSN:0021-9738
1558-8238
DOI:10.1172/JCI64256